
The pleural diseases market has witnessed considerable growth over the past few years owing to factors such increasing incidence of lung cancer and mesothelioma across the globe. Pleural diseases refer to medical conditions affecting the thin membrane known as the pleura lining the outside of the lungs and the inner chest wall. The market provides various products used for diagnosis and treatment of pleural effusion and pleural diseases such as drainage systems, pleural catheters, biopsy needles and others. Increasing lung cancer burden drives the demand for minimally invasive procedures used to drain fluid in pleural space and diagnose pleural effusions.
The Global Pleural Diseases Market is estimated to be valued at US$ 5.76 Bn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the Pleural Diseases Market Companies are Bristol Myers Squibb, Merck and Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical. These key players are focusing on launching new and advanced products to expand their product portfolio. The rising prevalence of lung cancer and mesothelioma is creating lucrative opportunities for players in the pleural diseases market. Introduction of novel drugs and treatment options are augmenting the demand. Technological advancements in devices used for diagnostic and therapeutic pleural procedures is fueling the market growth. The pleural diseases market is expanding globally owing to increasing healthcare investments and improving healthcare infrastructure across developing nations. Rising awareness regarding early diagnosis and availability of innovative treatment options are supporting the market penetration in emerging countries. Market Drivers The increasing prevalence of lung cancer worldwide is a major Pleural Diseases Market Growth. As per the Global Cancer Observatory (GCO), there were over 2.1 million new cases of lung cancer globally in 2020. Pleural effusion occurs as a complication of various non-malignant and malignant diseases including lung cancer. The growing burden of lung cancer cases necessitates diagnosis and management of pleural effusions, driving the demand for related technologies and procedures.
PEST Analysis Political: Regulations on healthcare and clinical trials may impact the growth and development of new drugs and diagnostic tests. Government support for research funding can boost innovation.
Economic: Growing healthcare expenditure and rising income levels in developing nations is driving demand. However, high treatment costs can be a barrier.
Social: Increasing awareness about respiratory diseases and advanced treatment options is encouraging patients to seek diagnosis and care. Population aging globally is also supporting market growth.
Technological: Investments in R&D are leading to new drugs, devices and diagnostic techniques. Advancements in areas like molecular diagnostics, imaging technologies and artificial intelligence offer potential for improved patient outcomes. The geographical regions where the pleural diseases market in terms of value is concentrated currently are North America and Europe. North America occupies the largest share owing to the rising prevalence of chronic lung disorders, rapid adoption of advanced diagnostic tools and presence of major industry players in the region. Europe is another major regional market supported by growing healthcare expenditure and availability of reimbursement. The Asia Pacific region is projected to be the fastest growing market for pleural diseases during the forecast period. This is attributed to factors such as increasing pollution levels and aging population base prone to respiratory illnesses, rising medical tourism, growing private and public healthcare spending creating wider access to diagnosis and treatment. In addition, improving research infrastructure and expanding healthcare capacities in countries like India, China and Japan are creating opportunities for market participants in Asia Pacific.
Get more insights on Pleural Diseases Market
For More Insights Discover the Report In language that Resonates with you
French | German | Russian | Japanese | Chinese | Korean | Portuguese
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)